Subbu Nambi
Stock Analyst at Guggenheim
(3.32)
# 1,088
Out of 5,239 analysts
81
Total ratings
44.44%
Success rate
5.29%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Reiterates: Buy | $21 | $13.30 | +57.89% | 3 | May 6, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $55 → $60 | $54.25 | +10.60% | 5 | May 5, 2026 | |
| CYRX Cryoport | Maintains: Buy | $11 → $12 | $13.13 | -8.61% | 2 | May 5, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $100 → $70 | $38.15 | +83.51% | 4 | May 5, 2026 | |
| DHR Danaher | Maintains: Buy | $275 → $235 | $165.49 | +42.00% | 4 | Apr 22, 2026 | |
| BRKR Bruker | Maintains: Buy | $58 → $50 | $44.31 | +12.84% | 6 | Mar 30, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $120 → $100 | $90.84 | +10.08% | 2 | Mar 30, 2026 | |
| GRAL GRAIL | Maintains: Buy | $130 → $75 | $61.10 | +22.75% | 4 | Mar 30, 2026 | |
| TEM Tempus AI | Maintains: Buy | $95 → $60 | $45.47 | +31.96% | 5 | Mar 30, 2026 | |
| VCYT Veracyte | Maintains: Buy | $50 → $45 | $38.93 | +15.61% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $4 | $3.02 | +32.45% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $440 | $348.94 | +26.10% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.62 | +51.52% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $6.81 | +90.90% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $144 → $170 | $147.50 | +15.25% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $96.76 | +39.52% | 8 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $18.26 | +157.39% | 3 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $8.71 | +37.77% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $199.07 | +35.63% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $98.85 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $15.28 | +135.60% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.98 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.55 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $112.27 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.27 | - | 1 | Dec 14, 2023 |
Adaptive Biotechnologies
May 6, 2026
Reiterates: Buy
Price Target: $21
Current: $13.30
Upside: +57.89%
Twist Bioscience
May 5, 2026
Maintains: Buy
Price Target: $55 → $60
Current: $54.25
Upside: +10.60%
Cryoport
May 5, 2026
Maintains: Buy
Price Target: $11 → $12
Current: $13.13
Upside: -8.61%
GeneDx Holdings
May 5, 2026
Maintains: Buy
Price Target: $100 → $70
Current: $38.15
Upside: +83.51%
Danaher
Apr 22, 2026
Maintains: Buy
Price Target: $275 → $235
Current: $165.49
Upside: +42.00%
Bruker
Mar 30, 2026
Maintains: Buy
Price Target: $58 → $50
Current: $44.31
Upside: +12.84%
BillionToOne
Mar 30, 2026
Maintains: Buy
Price Target: $120 → $100
Current: $90.84
Upside: +10.08%
GRAIL
Mar 30, 2026
Maintains: Buy
Price Target: $130 → $75
Current: $61.10
Upside: +22.75%
Tempus AI
Mar 30, 2026
Maintains: Buy
Price Target: $95 → $60
Current: $45.47
Upside: +31.96%
Veracyte
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $45
Current: $38.93
Upside: +15.61%
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $3.02
Upside: +32.45%
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $348.94
Upside: +26.10%
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $4.62
Upside: +51.52%
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $6.81
Upside: +90.90%
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $147.50
Upside: +15.25%
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $96.76
Upside: +39.52%
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $18.26
Upside: +157.39%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $8.71
Upside: +37.77%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $199.07
Upside: +35.63%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $98.85
Upside: -
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $15.28
Upside: +135.60%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.98
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.55
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $112.27
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.27
Upside: -